Association between plasma immunoproteasome and 90-day prognosis after first-ever ischemic stroke.

Chen, Xing-Yong; Fu, Ming; Wan, Shao-Fen; Zhang, Xu; Wang, Yin-Zhou

Chen, Xing-Yong; Fu, Ming; Wan, Shao-Fen; Zhang, Xu; Wang, Yin-Zhou.

Afiliación

Chen XY; Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
Fu M; Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
Wan SF; Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
Zhang X; Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
Wang YZ; Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.

Neural Regen Res ; 16(4): 790-795, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33063744

Palabras clave

behavior; biomarker; brain; clinical trial; cognitive impairment; immune function; neurological function; protein; stroke

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Ethics Idioma: En Revista: Neural Regen Res Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google